Abstract
Introduction: Renal cell carcinoma (RCC) is the most common type of renal cancer. Nowadays, most tumors are discovered incidentally at an early stage, thus changing the overall prognosis of the disease. Histological prognostic factors have been accepted as major prognostic factors for decades however, the predictive value of microvascular invasion (MVI) remains debatable. We performed this study to evaluate the prognostic role of MVI in RCC.
Patients and Methods: A cohort study, including 191 RCC patients undergoing laparoscopic retroperitoneal radical nephrectomy from January 2013 to April 2021 at Viet Duc University Hospita.
Results: the rate of microvascular invasion was 18/191 patients (9.4%), no microvascular invasion was 90.6%. The 3-5 year RFS of the MVI – and MVI + groups were 98.76 % and 81.45 %, respectively. The 3-5-year OS of the MVI – and MVI + groups were 99.28 % and 86.27 %, respectively; difference of p < 0.05. The MVI + group had an average tumor size of 60.8 mm, which was significantly larger than the MVI – group (52.8 mm) with p=0.038. In addition, MVI + is also associated with more unfavorable pathological features such as higher sRCC (sarcomatoid RCC) rate and higher Fuhrman grade (p<0.05).
Conclusion: The microvascular invasion group showed worse overall survival, and recurrence-metastasis results than the non-microvascular invasion group and was associated with more adverse factors. We suggest that MVI should be considered as an independent prognostic factor in renal cell carcinoma.
Keywords: renal cell carcinoma, microvascular invasion, recurrence-free survival
References
- Bedke J, Heide J, Ribback S, et al. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice. Bju International. 2018;121(1):84-92.
- Huang H, Pan X-W, Huang Y, et al. Microvascular invasion as a prognostic indicator in renal cell carcinoma: a systematic review and meta-analysis. International journal of clinical and experimental medicine. 2015;8(7):10779.
- Kroeger N, Rampersaud EN, Patard J-J, et al. Prognostic value of microvascular invasion in predicting the cancer specific survival and risk of metastatic disease in renal cell carcinoma: a multicenter investigation. The Journal of urology. 2012;187(2):418-423.
- Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of tumours of the urinary system and male genital organs—part A: renal, penile, and testicular tumours. European urology. 2016;70(1):93-105.
- Rey JR, Ramírez DL, García SL, Vázquez PF, Delgado JB, Calvo AO. Pathological prognostic indicators in renal cell carcinoma. Actas Urológicas Espa#olas (English Edition). 2010;34(1):71-77.
- Santiago-Agredano B, Álvarez-Kindelán J, Font-Ugalde P, Blanca-Pedregosa A, López-Beltrán A, Requena-Tapia MJ. Prognostic value of microvascular invasion in predicting survival in renal cell carcinoma. Actas Urológicas Espa#olas (English Edition). 2013;37(8):504-512.
- Kwon SY, Lee JN, Kim BS, et al. Impact of microvascular invasion and tumor necrosis on the prognosis of Korean patients with pT1b renal cell carcinoma. Urologia internationalis. 2015;95(1):65-71.
- Bengió RG, Arribillaga LC, Epelde J, et al. Evaluation of microvascular invasion as a prognostic factor in the progression of non-metastatic renal cancer. Central European journal of urology. 2018;71(4):386.
- Ishimura T, Sakai I, Hara I, Eto H, Miyake H. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery. International journal of urology. 2004;11(5):264-268.
- DallOglio MF, Antunes AA, Sarkis ÁS, et al. Microvascular tumour invasion in renal cell carcinoma: the most important prognostic factor. BJU international. 2007;100(3):552-555.